SCIENTURE HOLDINGS, INC. Net Income (Loss) Attributable to Noncontrolling Interest
SCIENTURE HOLDINGS, INC. (SCNX) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$437.77 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-22.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2024-04-22
- SCIENTURE HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-12-31 was -$377.84K.
- SCIENTURE HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-09-30 was -$25.74K.
- SCIENTURE HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$28.50K.
- SCIENTURE HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$5.69K.
- SCIENTURE HOLDINGS, INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$437.77K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$377.84K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | -$403.58K derived: sum of 2 quarters · filed 2024-04-22 | -$432.08K derived: sum of 3 quarters · filed 2024-04-22 | -$437.77K 10-K · filed 2024-04-22 |
| 2022-09-30 | -$25.74K 10-Q · filed 2024-01-16 | -$54.24K derived: sum of 2 quarters · filed 2024-01-16 | -$59.93K 10-Q · filed 2024-01-16 | |
| 2022-06-30 | -$28.50K 10-Q · filed 2023-08-18 | -$34.19K 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | -$5.69K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |